Polivir, also known as clopidogrel, is given for one year after a stent is placed in the heart, in combination with other antiplatelet aggregation medications, and can be discontinued if the condition is stable. It may need to be continued if there are frequent angina attacks or if the patient is at high risk of ischemia.
1. After one year of cardiac stenting, taking clopidogrel in combination with other antiplatelet aggregating drugs, such as aspirin, etc., patients who have stable heart conditions and are not at high risk of ischemia can stop taking clopidogrel as prescribed by the doctor.
2. After one year of cardiac stenting, if there are still frequent angina attacks, or if the patient is at high risk of ischemia, he/she may need to continue to take clopidogrel orally as prescribed by the doctor.
For most patients after cardiac stenting, one of the dual antiplatelet agents can be discontinued after 1 year, but for patients at high risk of ischemia or with recent unstable angina, the duration of the dual antiplatelet agent may be extended up to a maximum of 30 months.
Cardiac stenting one year to the hospital cardiovascular medicine clinic follow-up, under the guidance of the doctor’s interview to adjust the drug.